Wenhui Wu
Xinjiang Production and Construction Corps(CN)
Publications by Year
Research Areas
Genetic factors in colorectal cancer, Prostate Cancer Treatment and Research, Cancer Immunotherapy and Biomarkers, Cancer Cells and Metastasis, Cancer-related molecular mechanisms research
Most-Cited Works
- → Androgen receptor inhibitor–induced “BRCAness” and PARP inhibition are synthetically lethal for castration-resistant prostate cancer(2017)299 cited
- → High-resolution clonal mapping of multi-organ metastasis in triple negative breast cancer(2018)141 cited
- → Targeting the MYCN–PARP–DNA Damage Response Pathway in Neuroendocrine Prostate Cancer(2017)107 cited
- → miR-141-Mediated Regulation of Brain Metastasis From Breast Cancer(2016)82 cited
- → Safety and Efficacy of Panitumumab Plus Neoadjuvant Chemotherapy in Patients With Primary HER2-Negative Inflammatory Breast Cancer(2018)74 cited
- → PARP Inhibition Suppresses GR–MYCN–CDK5–RB1–E2F1 Signaling and Neuroendocrine Differentiation in Castration-Resistant Prostate Cancer(2019)73 cited
- → Molecular Landscape ofERBB2/ERBB3Mutated Colorectal Cancer(2018)67 cited
- → Naproxen chemoprevention promotes immune activation in Lynch syndrome colorectal mucosa(2020)62 cited
- → Molecular analyses from a phase I trial of vemurafenib to study mechanism of action (MOA) and resistance in repeated biopsies from BRAF mutation–positive metastatic melanoma patients (pts).(2011)38 cited
- → Genomic Landscape of Lynch Syndrome Colorectal Neoplasia Identifies Shared Mutated Neoantigens for Immunoprevention(2024)26 cited